Literature DB >> 20727477

Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009.

Juraj Majtan1, Lubica Majtanova, Viktor Majtan.   

Abstract

A 5-year survey from 2005 to 2009 revealed an increasing trend of resistance to nalidixic acid (from 0% in 2005 to 11% in 2009) among 858 clinical isolates of Salmonella Typhimurium. In addition, 10 ceftriaxone-resistant and 3 ciprofloxacin-resistant Salmonella Typhimurium isolates were detected over the period of study.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20727477     DOI： 10.1016/j.diagmicrobio.2010.04.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  4 in total

1.  Phenotypic and molecular characterization of human salmonella enterica serovar 4,[5],12:i:- isolates in Slovakia.

Authors:  Viktor Majtan; Lubica Majtanova; Juraj Majtan
Journal:  Curr Microbiol       Date:  2011-09-10       Impact factor: 2.188

Review 2.  Antimicrobial resistance and management of invasive Salmonella disease.

Authors:  Samuel Kariuki; Melita A Gordon; Nicholas Feasey; Christopher M Parry
Journal:  Vaccine       Date:  2015-04-23       Impact factor: 3.641

Review 3.  Epidemiology and Genomics of Invasive Nontyphoidal Salmonella Infections in Kenya.

Authors:  Samuel Kariuki; Robert S Onsare
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079

4.  Ceftriaxone-resistant Salmonella enterica serotype typhimurium sequence type 313 from Kenyan patients is associated with the blaCTX-M-15 gene on a novel IncHI2 plasmid.

Authors:  Samuel Kariuki; Chinyere Okoro; John Kiiru; Samuel Njoroge; Geoffrey Omuse; Gemma Langridge; Robert A Kingsley; Gordon Dougan; Gunturu Revathi
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.